SIRT6 overexpression can improve hepatic steatosis, insulin resistance, and inflammation, which regulates hepatic steatosis by interacting with USP10 and inhibiting SIRT6 ubiquitin and degradation [172]. This evidence concerns the gene USP10 and fatty liver disease.